Townsquare Capital LLC Buys 305 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Townsquare Capital LLC raised its position in HCA Healthcare, Inc. (NYSE:HCA) by 12.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,687 shares of the company’s stock after purchasing an additional 305 shares during the quarter. Townsquare Capital LLC’s holdings in HCA Healthcare were worth $1,092,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of HCA. Alpha DNA Investment Management LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $869,000. EP Wealth Advisors LLC lifted its position in HCA Healthcare by 1.6% during the 2nd quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company’s stock worth $72,335,000 after buying an additional 3,516 shares in the last quarter. AustralianSuper Pty Ltd grew its holdings in shares of HCA Healthcare by 118.5% in the 3rd quarter. AustralianSuper Pty Ltd now owns 35,493 shares of the company’s stock valued at $14,425,000 after acquiring an additional 19,247 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in HCA Healthcare by 3.3% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 162,654 shares of the company’s stock valued at $52,257,000 after purchasing an additional 5,136 shares during the last quarter. Finally, Mizuho Securities USA LLC increased its position in shares of HCA Healthcare by 205.4% during the 3rd quarter. Mizuho Securities USA LLC now owns 45,637 shares of the company’s stock worth $18,548,000 after purchasing an additional 30,693 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Trading Up 0.1 %

Shares of HCA Healthcare stock opened at $327.62 on Tuesday. The firm’s 50-day moving average price is $371.88 and its two-hundred day moving average price is $358.84. The company has a market capitalization of $82.99 billion, a price-to-earnings ratio of 14.71, a PEG ratio of 1.26 and a beta of 1.68. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 12-month low of $250.67 and a 12-month high of $417.14.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.81%. HCA Healthcare’s payout ratio is 11.85%.

Insider Activity at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This trade represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock valued at $5,608,990 over the last ninety days. 1.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts recently weighed in on HCA shares. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their target price for the stock from $400.00 to $320.00 in a report on Monday, November 25th. Barclays cut their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research note on Friday, November 8th. Morgan Stanley initiated coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective for the company. UBS Group increased their price target on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Finally, TD Cowen dropped their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $380.29.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.